ADAMIS PHARMACEUTICALS CORP (ADMP)       0.1853  -0.01 (-3.74%)

0.1853  -0.01 (-3.74%)

US00547W2089 - Common Stock - After market: 0.185 0 (-0.16%)

ADAMIS PHARMACEUTICALS CORP0.1853

NASDAQ:ADMP (12/6/2022, 7:19:55 PM)-0.01 (-3.74%)

After market: 0.185 0 (-0.16%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Pharmaceuticals
Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend
Overview
Earnings (Last) 11-14 2022-11-14/amc Earnings (Next) 03-29 2023-03-29
Ins Owners 0.67% Inst Owners 8.57%
Market Cap 27.79M Shares 149.98M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 43.33
IPO 08-14 1995-08-14

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ADMP Daily chart

Company Profile

Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development, and sale of pharmaceutical, specialty biopharmaceutical, and other drug products. The company is headquartered in San Diego, California and currently employs 15 full-time employees. The firm is focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory diseases. Its products and product candidates in the allergy, respiratory, and opioid overdose markets include SYMJEPI (epinephrine) Injection 0.3mg, which is used in the emergency treatment of acute allergic reactions, including anaphylaxis, for patients weighing 66 pounds or more; and SYMJEPI (epinephrine) Injection 0.15mg, which is used in the treatment of anaphylaxis for patients weighing 33-65 pounds. Its other product candidates include ZIMHI (naloxone) Injection, which is used for the treatment of opioid overdose; and Tempol (APC-400), an investigational drug, which is used in the fields of COVID-19 infection, asthma, respiratory syncytial virus infection, and influenza infection. The company also has a microbicide product candidate, named C31G.

Company Info

ADAMIS PHARMACEUTICALS CORP

Suite 310, 11455 El Camino Real

San Diego CALIFORNIA 92130

P: 18589972400.0

CEO: Dennis J. Carlo

Employees: 15

Website: http://www.adamispharmaceuticals.com/

ADMP News

News Image22 days ago - Adamis Pharmaceuticals CorporationAdamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Management to host webcast/conference call today at 2:00 p.m. PT / 5:00 p.m. ...

News Imagea month ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

We're starting off the day with an overview of the biggest pre-market stock movers on Tuesday and the latest news this morning!

News Image2 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Good morning, investor! We're starting off Thursday with a breakdown of the biggest pre-market stock movers this morning!

News Image2 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

It's time for another dive into the biggest pre-market stock movers as we check out what's behind shares moving on Wednesday!

ADMP Twits

Here you can normally see the latest stock twits on ADMP, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example